FOXO4‑DRI 10 mg
FOXO4‑DRI 10 mg is a synthetic peptide designed to inhibit FOXO4-mediated protein interactions. Consequently, it is widely used in controlled laboratory research, analytical workflows, and in‑vitro studies. Researchers utilize it to explore cellular senescence, protein–protein interactions, and aging-related mechanistic pathways. Additionally, its sequence incorporates a cell-penetrating domain, which enhances intracellular delivery and supports precise experimental investigations. Supplied as a lyophilised powder, FOXO4‑DRI maintains stability and high purity, ensuring consistent laboratory results.
Specifications
| Product | FOXO4-DRI 10mg |
|---|---|
| Also known as | FOXO4 D-retro-inverso peptide; Proxofim |
| CAS number | 2460055-10-9 |
| PubChem CID | 167312269 |
| Molecular formula | C228H388N86O64 |
| Molecular weight | 5,358 g/mol |
| Compound class | Synthetic D-retro-inverso peptide |
| Form | White lyophilised powder, supplied in a clear glass vial |
| Quantity | 10 mg per vial |
| Purity | HPLC-tested; certificate of analysis supplied with each batch |
| Storage | Lyophilised: 4 °C for up to 1 year, or −20 °C for up to 3 years. Reconstituted: 4 °C for up to 28 days. |
| Product code | F410 (QR code on the vial label) |
| Intended use | For research purposes only. Not for human or veterinary use. |
Identifiers verified against PubChem, CAS Common Chemistry and FDA GSRS (PubChem / MedChemExpress), 1 November 2026.
Key Features
FOXO4‑DRI is derived from the FOXO4 interaction domain. Therefore, it is optimized for high-purity laboratory studies. Its cell-penetrating domain facilitates intracellular uptake, which improves experimental reproducibility. Researchers can investigate senescence-associated pathways with greater precision. Furthermore, the peptide allows mechanistic exploration of protein–protein interactions under controlled conditions. As a result, it is particularly valuable in studies that demand accuracy and repeatability.
Storage & Stability
- Long-term: Store at –20 °C in a dry, sealed container
- Short-term: Maintain under standard laboratory cold-chain conditions
- Handling: Protect from moisture and avoid repeated freeze–thaw cycles
Intended Use
- For laboratory research only
- Not for human or animal consumption
- Not approved for diagnostic, therapeutic, or medical applications
- Handle using standard laboratory safety procedures
Why Choose FOXO4‑DRI 10 mg?
- High-purity peptide suitable for precision research
- COA included for batch verification and documentation
- Lyophilised format ensures stability during storage and shipping
- UK‑stocked for rapid and reliable delivery
| Weight | 50 g |
|---|---|
| Dimensions | 1 × 1 × 3 cm |
